Head-to-Head Trial Supports New Treatment for Kids With MS – Medscape

Written by

admin

in

  1. Head-to-Head Trial Supports New Treatment for Kids With MS  Medscape
  2. Ocrelizumab Shows Similar Efficacy to Fingolimod in Phase 3 OPERETTA 2 Trial for Pediatric Relapsing-Remitting MS  Neurology Live
  3. Genentech Presents New Data for Ocrevus and Fenebrutinib Across Broad Patient Populations at ECTRIMS 2025  BioSpace
  4. Roche bids to broaden MS pipeline and strengthen Ocrevus influence  Yahoo Finance
  5. Ocrelizumab provides superior control of multiple sclerosis relapses compared to other therapies  News-Medical

Continue Reading

More posts